--- title: Mixing and Matching COVID-19 Doses Might Be More Effective description: The first large study of mixing and matching COVID-19 vaccine doses reveals encouraging news, especially as booster shots roll out in the U.S. canonical: https://time.com/6107027/covid-vaccine-mix-and-match/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2021-10-15T10:00:38.000Z article:modified_time: 2026-10-14T09:15:38.609Z article:section: Health og:title: First Studies Show It’s Possible to Mix Pfizer-BioNTech, Moderna and J&J Vaccine Doses og:description: The first large study of mixing and matching COVID-19 vaccine doses reveals encouraging news, especially as booster shots roll out in the U.S. og:url: https://time.com/6107027/covid-vaccine-mix-and-match/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt5ded27a9fd5da52c/698a1dbe16d8840117c39d57/GettyImages-1303673688.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 5472 og:image:height: 3078 og:image:alt: Covid-19 Vaccine og:type: article twitter:card: summary_large_image twitter:title: First Studies Show It’s Possible to Mix Pfizer-BioNTech, Moderna and J&J Vaccine Doses twitter:description: The first large study of mixing and matching COVID-19 vaccine doses reveals encouraging news, especially as booster shots roll out in the U.S. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt5ded27a9fd5da52c/698a1dbe16d8840117c39d57/GettyImages-1303673688.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # A New Study Makes the Case for Mixing and Matching the Pfizer-BioNTech, Moderna and J&J Vaccine Doses > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7beefd73-c95f-4206-8390-c8d0f31c67b8&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7beefd73-c95f-4206-8390-c8d0f31c67b8&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=7beefd73-c95f-4206-8390-c8d0f31c67b8&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7beefd73-c95f-4206-8390-c8d0f31c67b8&cr=time-nl-network-2026q3-v1) ## Video: Joe Biden Gets His Booster Shot [Watch (HLS stream): Joe Biden Gets His Booster Shot](https://cdn.jwplayer.com/manifests/SL886l7F.m3u8) (3:17)  _Published 2021-09-27. President Joe Biden received his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older and approved them for others with preexisting medical conditions and high-risk work environments._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Oct 15, 2021 10:00 AM UTC  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Oct 15, 2021 10:00 AM UTC As soon as health officials made it clear that the world would [need a booster dose](https://time.com/6099368/booster-doses-fda-panel/) of the COVID-19 vaccine, they needed to know if people could mix doses of vaccines made by different manufacturers. In the first [study](https://www.medrxiv.org/content/10.1101/2021.10.10.21264827v1) to provide results on such cross-dosing, researchers say that it’s safe for people who received one of the three vaccines available in the U.S. to get a booster dose of another—and that they found early evidence that certain combinations might generate stronger immune responses than others. The study was published on a preprint server and not yet peer-reviewed, and came on the same day that the Food and Drug Administration (FDA) convened a panel of outside experts to review Moderna’s request to authorize a booster shot. The FDA and Centers for Disease Control have [issued an emergency use authorization for Pfizer-BioNTech’s booster,](https://time.com/6100971/fda-booster-shot-authorization/) but is currently reviewing data on the safety and efficacy of booster from Moderna and J&J. For the mix-and-match study, the researchers studied 458 people who were originally immunized with Pfizer-BioNTech, [Moderna](https://time.com/5922752/moderna-covid-19-vaccine-approved-fda-emergency-use/) or [Johnson&Johnson-Janssen](https://time.com/collection-post/5943102/johnson-and-johnson-covid-vaccine-info/) vaccines and then randomly assigned to get a booster dose of one of the three, about four to six months later. It wasn’t designed to directly compare immune responses of one booster to another, but rather to give researchers a broad sense of whether overall, the antibody responses produced were similar across all three boosters—for example, to see whether people who initially got Pfizer-BioNTech’s vaccine produced similar immune responses after getting an additional dose of a Pfizer-BioNTech, Moderna or J&J’s shot. In general, people who received a booster of a vaccine that was different from the one they originally received saw antibody increases that were similar to or higher than in those who had received another dose of the same vaccine of their initial shot(s). There were small differences, however. People who received the single J&J vaccine experienced higher jumps in levels neutralizing antibodies after getting a booster dose of the Pfizer-BioNTech or Moderna vaccines, compared to another dose of the J&J vaccine: 50-fold for the former two vs. 5-fold for the latter. It’s not clear why, but it could be related to the fact that J&J’s vaccine relies on a different technology than the ones made by Pfizer-BioNTech and Moderna. The J&J shot uses an adenovirus vector to deliver viral genes to the immune system, which then recognizes them as foreign and mounts an attack, while Pfizer-BioNTech’s and Moderna’s vaccines utilize a new technology of delivering the mRNA form of SARS-CoV-2’s genetic material directly. And there is is some early evidence that the different technologies may be able to elicit different types of immunity—some preliminary data suggests, for example, that J&J’s vaccine may be more effective in quickly boosting T-cell-based responses that might be more durable and able to recognize new variants than the move heavily antibody-based responses Moderna and Pfizer-BioNTech generate initially. The FDA will be considering such data as it evaluates booster shots from Moderna and J&J-Janssen on Oct. 14 and Oct. 15. The findings are encouraging because they suggest that it’s safe for providers to mix and match doses when it comes to boosters. Public health experts have advocated that everyone who has been immunized against COVID-19 get a booster shot to combat waning protection from the vaccines in the face of the faster-spreading Delta variant, and the ability to get any of the three vaccines will ensure that more people will get the additional shot. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6107027/covid-vaccine-mix-and-match/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6107027/covid-vaccine-mix-and-match/"},"headline":"A New Study Makes the Case for Mixing and Matching the Pfizer-BioNTech, Moderna and J&J Vaccine Doses","datePublished":"2021-10-15T10:00:38.000Z","dateModified":"2026-10-14T09:15:38.609Z","description":"The first large study of mixing and matching COVID-19 vaccine doses reveals encouraging news","url":"https://time.com/6107027/covid-vaccine-mix-and-match/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt5ded27a9fd5da52c/698a1dbe16d8840117c39d57/GettyImages-1303673688.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt5ded27a9fd5da52c/698a1dbe16d8840117c39d57/GettyImages-1303673688.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Covid-19 Vaccine","caption":"Covid-19 Vaccine","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6107027/covid-vaccine-mix-and-match/","name":"A New Study Makes the Case for Mixing and Matching the Pfizer-BioNTech, Moderna and J&J Vaccine Doses"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Joe Biden Gets His Booster Shot","description":"President Joe Biden received his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older and approved them for others with preexisting medical conditions and high-risk work environments.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/SL886l7F/poster.jpg?width=720","uploadDate":"2021-09-27T18:39:00.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/SL886l7F.m3u8","embedUrl":"https://time.com/6107027/covid-vaccine-mix-and-match/","duration":"PT3M17S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6107027/covid-vaccine-mix-and-match/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```